Longitudinal development of incident gout from low-normal baseline serum urate concentrations: individual participant data analysis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2520-1026
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Longitudinal development of incident gout from low-normal baseline serum urate concentrations: individual participant data analysis ; volume:5 ; number:1 ; day:28 ; month:8 ; year:2021 ; pages:1-8 ; date:12.2021
BMC Rheumatology ; 5, Heft 1 (28.8.2021), 1-8, 12.2021
- Creator
-
Robinson, Philip C.
Frampton, Christopher
Phipps-Green, Amanda
Neogi, Tuhina
Stamp, Lisa
Taylor, William
Merriman, Tony R.
Dalbeth, Nicola
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s41927-021-00204-4
- URN
-
urn:nbn:de:101:1-2021110918001167146346
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Robinson, Philip C.
- Frampton, Christopher
- Phipps-Green, Amanda
- Neogi, Tuhina
- Stamp, Lisa
- Taylor, William
- Merriman, Tony R.
- Dalbeth, Nicola
- SpringerLink (Online service)
Other Objects (12)
Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
The renal urate transporter SLC17A1 locus: confirmation of association with gout
Unraveling the pathological biomineralization of monosodium urate crystals in gout patients
The relationship between ferritin and urate levels and risk of gout
Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare
Effect of omega-three supplementation on serum urate and gout flares in people with gout; a pilot randomized trial
Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
The renal urate transporter SLC17A1 locus: confirmation of association with gout
Unraveling the pathological biomineralization of monosodium urate crystals in gout patients
The relationship between ferritin and urate levels and risk of gout
Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare
Effect of omega-three supplementation on serum urate and gout flares in people with gout; a pilot randomized trial
Untangling the complex relationships between incident gout risk, serum urate, and its comorbidities
Variation in serum urate levels in the absence of gout and urate lowering therapy
Adherence with urate-lowering therapies for the treatment of gout
Urate-lowering therapy, serum urate, inflammatory biomarkers, and renal function in patients with gout following pegloticase discontinuation
The renal urate transporter SLC17A1 locus: confirmation of association with gout
Unraveling the pathological biomineralization of monosodium urate crystals in gout patients
The relationship between ferritin and urate levels and risk of gout
Fluctuation and change of serum urate levels and flares in gout: results from the NOR-Gout study
Baseline urate level and renal function predict outcomes of urate-lowering therapy using low doses of febuxostat and benzbromarone: a prospective, randomized controlled study in a Chinese primary gout cohort
Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout
Prognostic factors associated with early gout flare recurrence in patients initiating urate-lowering therapy during an acute gout flare